Immunomodulation in Type 1 Diabetes by NBI-6024, an Altered Peptide Ligand of the Insulin B(9−23) Epitope.

Saved in:
Bibliographic Details
Title: Immunomodulation in Type 1 Diabetes by NBI-6024, an Altered Peptide Ligand of the Insulin B(9−23) Epitope.
Authors: Alleva, D. G.1, Maki, R. A.1 rmaki@neurocrine.com, Putnam, A. L.2, Robinson, J. M.1, Kipnes, M. S.3, Dandona, P.4, Marks, J. B.5, Simmons, D. L.6, Greenbaum, C. J.7, Jimenez, R. G.1, Conlon, P. J.1, Gottlieb, P. A.2
Source: Scandinavian Journal of Immunology. Jan2006, Vol. 63 Issue 1, p59-69. 11p. 3 Charts, 4 Graphs.
Database: Academic Search Ultimate
Description
ISSN:03009475
DOI:10.1111/j.1365-3083.2005.01705.x